Please use this identifier to cite or link to this item: https://doi.org/10.1080/14656566.2024.2334424
DC FieldValue
dc.titleEfficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review
dc.contributor.authorAlexia Leber
dc.contributor.authorRanuk Ramachandra
dc.contributor.authorFelicia Ceban
dc.contributor.authorAngela Kwan
dc.contributor.authorTeoho Greg Rhee
dc.contributor.authorJie Wu
dc.contributor.authorBing Cao
dc.contributor.authorMuhammad Youshay Jawad
dc.contributor.authorKayla M Teopiz
dc.contributor.authorRoger Ho
dc.contributor.authorGia Han Le
dc.contributor.authorDiluk Ramachandra
dc.contributor.authorRoger S. McIntyre
dc.date.accessioned2024-05-06T02:56:50Z
dc.date.available2024-05-06T02:56:50Z
dc.date.issued2024-03-27
dc.identifier.citationAlexia Leber, Ranuk Ramachandra, Felicia Ceban, Angela Kwan, Teoho Greg Rhee, Jie Wu, Bing Cao, Muhammad Youshay Jawad, Kayla M Teopiz, Roger Ho, Gia Han Le, Diluk Ramachandra, Roger S. McIntyre (2024-03-27). Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review. Expert Opinion on Pharmacotherapy 25 (4) : 467-476. ScholarBank@NUS Repository. https://doi.org/10.1080/14656566.2024.2334424
dc.identifier.issn1465-6566
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/248254
dc.publisherTaylor & Francis
dc.sourceTaylor & Francis
dc.typeArticle
dc.contributor.departmentPSYCHOLOGICAL MEDICINE
dc.description.doi10.1080/14656566.2024.2334424
dc.description.sourcetitleExpert Opinion on Pharmacotherapy
dc.description.volume25
dc.description.issue4
dc.description.page467-476
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108014656566.2024.2334424.zip2.41 MBZIP

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.